SFX by Ex Libris Inc.

Title:	A model for the mechanism of human topoisomerase I
Source:	Science [0036-8075] Stewart, L yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Champoux, James J J. "DNA topoisomerases: Structure, function, and mechanism." Annual review of biochemistry 70.1 (2001): 369-413.
description	2.	Redinbo, Matthew R. "Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA." Science 279.5356 (1998): 1504-1513.
description	3.	Champoux, James J. "DNA topoisomerases: structure, function, and mechanism. [Erratum to document cited in CA135:177032]." Annual Review of Biochemistry 71 (2002).
description	4.	Jensen, A. "Purification and characterization of human topoisomerase I mutants." European journal of biochemistry 236.2: 389-394.
description	5.	Hsiang, Y H H. "Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I." The Journal of biological chemistry 260.27 (1985): 14873-8.
description	6.	Wang, James C C. "Cellular roles of DNA topoisomerases: A molecular perspective." Nature reviews. Molecular cell biology 3.6 (2002): 430-440.
description	7.	Wang, J C C. "DNA topoisomerases." Annual review of biochemistry 65.1 (1996): 635-692.
description	8.	Kellner, U. "Culprit and victim â DNA topoisomerase II." Lancet oncology 3.4 (2002): 235-243.
description	9.	Marchand, C. "DNA topoisomerases and their poisoning by anticancer and antibacterial drugs." Chemistry & biology 17.5 (2010): 421-433.
description	10.	Koga, M. "Synthesis and Physicochemical Properties of Alternating Î±,Î²-Oligodeoxyribonucleotides with Alternating (3'â3')- and (5'â5')-Internucleotidic Phosphodiester Linkages." Journal of organic chemistry 60.6 (1995): 1520-1530.
description	11.	Yao, Y. "Synthesis of CdS nanoparticles based on DNA network templates." Nanotechnology 19.40 (2008): 405601-.
description	12.	Kehrer, D. "Modulation of camptothecin analogs in the treatment of cancer: a review." Anti-cancer drugs 12.2 (2001): 89-105.
description	13.	Ulukan Hulya, H. "Camptothecins: a review of their chemotherapeutic potential." Drugs 62.14 (2002): 2039-2057.
description	14.	SLICHENMYER, Scott J. "THE CURRENT STATUS OF CAMPTOTHECIN ANALOGS AS ANTITUMOR AGENTS." Journal of the National Cancer Institute 85.4 (1993): 271-291.
description	15.	Tao, Z. "Synthesis and biological evaluation of 4'-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors." Bioorganic & medicinal chemistry letters 17.15 (2007): 4308-2442.
description	16.	Durst, M.. "A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions." Proceedings of the National Academy of Sciences of the United States of America 80.12 (1983): 3812-3815.
description	17.	Elion, G B B. "The biochemistry and mechanism of action of acyclovir." The journal of antimicrobial chemotherapy 12 Suppl B.SUPPL. B (1983): 9-17.
description	18.	ENNIS, H L L. "CYCLOHEXIMIDE: ASPECTS OF INHIBITION OF PROTEIN SYNTHESIS IN MAMMALIAN CELLS." Science 146.365 (1965): 1474-6.
description	19.	Steller, H. "Mechanisms and genes of cellular suicide." Science 267.5203 (1995): 1445-9.
description	20.	Formenti, F. "Regulation of human metabolism by hypoxia-inducible factor." Proceedings of the National Academy of Sciences of the United States of America 107.June 28 2010 (2010): 12722-12727.